Modèles transgéniques pour l'étude de la fonction ... - Epublications

Theocharis, A. D., Seidel, C., Borset, M., Dobra, K., Baykov, V., Labropoulou, V.,
Kanakis, I., Dalas, E., Karamanos, N. K., Sundan, A. et al. (2006). Serglycin constitutively
secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro. J Biol
Chem 281, 35116-28.
Thompson, A., Timmers, E., Schuurman, R. K. and Hendriks, R. W. (1995).
Immunoglobulin heavy chain germ-line JH-C mu transcription in human precursor B
lymphocytes initiates in a unique region upstream of DQ52. Eur J Immunol 25, 257-61.
Thompson, L. D., Pantoliano, M. W. and Springer, B. A. (1994). Energetic
characterization of the basic fibroblast growth factor-heparin interaction: identification of the
heparin binding domain. Biochemistry 33, 3831-40.
Tiegs, S. L., Russell, D. M. and Nemazee, D. (1993). Receptor editing in self-reactive
bone marrow B cells. J Exp Med 177, 1009-20.
Tonegawa, S. (1983). Somatic generation of antibody diversity. Nature 302, 575-81.
Toyama-Sorimachi, N., Sorimachi, H., Tobita, Y., Kitamura, F., Yagita, H., Suzuki,
K. and Miyasaka, M. (1995). A novel ligand for CD44 is serglycin, a hematopoietic cell
lineage-specific proteoglycan. Possible involvement in lymphoid cell adherence and activation. J
Biol Chem 270, 7437-44.
Toyama, H., Okada, S., Hatano, M., Takahashi, Y., Takeda, N., Ichii, H., Takemori,
T., Kuroda, Y. and Tokuhisa, T. (2002). Memory B cells without somatic hypermutation are
generated from Bcl6-deficient B cells. Immunity 17, 329-39.
Tsukada, S., Sugiyama, H., Oka, Y. and Kishimoto, S. (1990). Estimation of D
segment usage in initial D to JH joinings in a murine immature B cell line. Preferential usage of
DFL16.1, the most 5' D segment and DQ52, the most JH-proximal D segment. J Immunol 144,
4053-9.
Tumova, S., Woods, A. and Couchman, J. R. (2000). Heparan sulfate chains from
glypican and syndecans bind the Hep II domain of fibronectin similarly despite minor structural
differences. J Biol Chem 275, 9410-7.
Turner, M., Mee, P. J., Costello, P. S., Williams, O., Price, A. A., Duddy, L. P.,
Furlong, M. T., Geahlen, R. L. and Tybulewicz, V. L. (1995). Perinatal lethality and blocked
B-cell development in mice lacking the tyrosine kinase Syk. Nature 378, 298-302.
Uhlin-Hansen, L., Wik, T., Kjellen, L., Berg, E., Forsdahl, F. and Kolset, S. O.
(1993). Proteoglycan metabolism in normal and inflammatory human macrophages. Blood 82,
2880-9.
Umana, P., Jean-Mairet, J., Moudry, R., Amstutz, H. and Bailey, J. E. (1999).
Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent
cellular cytotoxic activity. Nat Biotechnol 17, 176-80.
Van den Steen, P., Rudd, P. M., Dwek, R. A., Van Damme, J. and Opdenakker, G.
(1998). Cytokine and protease glycosylation as a regulatory mechanism in inflammation and
autoimmunity. Adv Exp Med Biol 435, 133-43.
van Horssen, J., Wesseling, P., van den Heuvel, L. P., de Waal, R. M. and Verbeek,
M. M. (2003). Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related
disorders. Lancet Neurol 2, 482-92.
Venkitaraman, A. R., Williams, G. T., Dariavach, P. and Neuberger, M. S. (1991).
The B-cell antigen receptor of the five immunoglobulin classes. Nature 352, 777-81.
Vidal y Plana, R. R. and Karzel, K. (1980). [Glucosamine: its value for the metabolism
of articular cartilage. 1. Biochemistry of proteoglycans, studies on in-vitro cultures of embryonal
mouse fibroblasts and bone germs]. Fortschr Med 98, 557-62.
Vijay, I. K. (1998). Developmental and hormonal regulation of protein N-glycosylation
in the mammary gland. J Mammary Gland Biol Neoplasia 3, 325-36.
176